Genes and Cancer publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Its Editorial Board consists of outstanding scientists who are well known for their contributions in the fields of oncogenes/oncoproteins, signal transduction, cancer therapy and other fields of biology and medicine.Cancer research has entered a new and exciting phase where the convergence of information from genomics, bioinformatics and modern genetics are beginning to provide new clues into how cancer cells overcome growth regulatory pathways. To capture this excitement, Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, we hope to attract papers in the areas of genomics, drug development and systems biology.According to Scopus/SJR/Journal rank, Genes & Cancer ranks Q1 (highest group), thus becoming a leading journal in the field of cancer and genetics. In the "Cancer Research" category, Genes & Cancer ranks 20nd out of 195 journals (click here to view journal rankings).